Skip to main content
Caplight Logo









Defymed

Defymed

Private
StrasbourgHealthcare & Life Scienceshttps://defymed.com

Company Overview

Defymed is a biotechnology company that develops and markets implantable bio-artificial medical devices for the physiological delivery of therapeutic compounds, with an initial focus on treating type 1 diabetes.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Biotechnology

Business Model

B2B

Customer Profile

Hardware Sales

AI Layer

Non-AI

Keywords

medical devicebio-artificial pancreascell encapsulationimplantable devicetype 1 diabetesdrug deliverycell therapyimplantable pancreasbio-artificial organdiabetes techbiotechmedtechglucose regulationmacro-encapsulationregenerative medicine

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Defymed Comparables

Compare Defymed with similar companies based on industry and business-model similarity.

Defymed comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Betalin Therapeutics
84%
Encellin
81%
Sernova Biotherapeutics Inc.
81%

Defymed Funding Rounds

Historical fundraising activity

View Full Funding History

Access detailed round history, amounts raised, valuations, and investors.

Defymed Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Defymed Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Defymed's valuation, stock price, and market status.

Firmographic Details

HeadquartersStrasbourg
Year Founded2011
Last Funding

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?